2016's drug pric­ing head­winds threat­en a hur­ri­cane of new reg­u­la­tions

Those head­winds aimed at rou­tine drug price in­creas­es in the US is now be­com­ing a gale force po­lit­i­cal storm that is draw­ing down share prices …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.